In addition, DLL3 was highly expressed in many cancers and elevation of DLL3 enhanced the development of many cancers, including small-cell lung cancers [10, 11], pituitary adenomas [12, 13], breast cancer [14, 15], and acute myeloid leukemia [16]. This evidence concerns the gene DLL3 and breast carcinoma.